Market Cap for Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported market cap is $116.11B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$116.11B
YoY change
-6.6%
5Y CAGR
+13.9%
Peak year (2025)
$116.97B
Latest annual
$109.20B
Market Cap history chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2026
Market Cap history table for Vertex Pharmaceuticals (VRTX) from 1991 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $109.20B | -6.6% | ||
| 2025 | $116.97B | +12.6% | ||
| 2024 | $103.86B | -2.0% | ||
| 2023 | $105.99B | +41.7% | ||
| 2022 | $74.82B | +31.1% | ||
| 2021 | $57.07B | -8.3% | ||
| 2020 | $62.25B | +9.1% | ||
| 2019 | $57.07B | +32.9% | ||
| 2018 | $42.95B | +13.2% | ||
| 2017 | $37.95B | +110.5% | ||
| 2016 | $18.03B | -40.6% | ||
| 2015 | $30.36B | +8.6% | ||
| 2014 | $27.95B | +67.3% | ||
| 2013 | $16.71B | +88.2% | ||
| 2012 | $8.88B | +28.1% | ||
| 2011 | $6.93B | -1.2% | ||
| 2010 | $7.02B | -5.4% | ||
| 2009 | $7.42B | +73.9% | ||
| 2008 | $4.27B | +42.5% | ||
| 2007 | $3.00B | -29.3% | ||
| 2006 | $4.24B | +71.6% | ||
| 2005 | $2.47B | +197.3% | ||
| 2004 | $830.50M | +4.2% | ||
| 2003 | $796.99M | -33.6% | ||
| 2002 | $1.20B | -34.4% | ||
| 2001 | $1.83B | -62.2% | ||
| 2000 | $4.84B | +441.8% | ||
| 1999 | $893.13M | +18.7% | ||
| 1998 | $752.65M | -6.0% | ||
| 1997 | $800.71M | +6.4% | ||
| 1996 | $752.34M | +66.4% | ||
| 1995 | $452.18M | +91.8% | ||
| 1994 | $235.71M | +1.9% | ||
| 1993 | $231.25M | +95.3% | ||
| 1992 | $118.39M | +9.8% | ||
| 1991 | $107.79M | — |
Market Cap values are taken from Vertex Pharmaceuticals's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2026 fiscal year, Vertex Pharmaceuticals (VRTX) reported market cap of $109.20B – declined 6.6% year-over-year.
Vertex Pharmaceuticals market cap has recorded the values shown across consecutive periods, with a +13.9% compound annual growth rate over 2021–2026 (5 years).
Between 2025 and 2026, Vertex Pharmaceuticals market cap declined 6.6%, falling from $116.97B to $109.20B.
The highest annual market cap of $116.97B was reported in 2025. The lowest in the available history was $107.79M in 1991.
Within Healthcare, Vertex Pharmaceuticals (VRTX) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.
Vertex Pharmaceuticals Market Cap by Year
Vertex Pharmaceuticals Market Cap 2026: $109.20B
Vertex Pharmaceuticals market cap in 2026 was $109.20B, declined 6.6% below 2025.
Vertex Pharmaceuticals Market Cap 2025: $116.97B
Vertex Pharmaceuticals market cap in 2025 was $116.97B, grew 12.6% from 2024. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals Market Cap 2024: $103.86B
Vertex Pharmaceuticals market cap in 2024 was $103.86B, edged down 2.0% below 2023.
Vertex Pharmaceuticals Market Cap 2023: $105.99B
Vertex Pharmaceuticals market cap in 2023 was $105.99B, surged 41.7% from 2022.
Vertex Pharmaceuticals Market Cap 2022: $74.82B
Vertex Pharmaceuticals market cap in 2022 was $74.82B.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers — Market Cap
Companies in the same sector as Vertex Pharmaceuticals, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Vertex Pharmaceuticals's market cap?
- Latest reported market cap for Vertex Pharmaceuticals (VRTX) is $116.11B (period ending December 31, 2025).
How has Vertex Pharmaceuticals market cap changed year-over-year?
- Vertex Pharmaceuticals (VRTX) market cap changed -6.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Vertex Pharmaceuticals market cap?
- Vertex Pharmaceuticals (VRTX) market cap compound annual growth rate is +13.9% over the most recent 5 years available.
When did Vertex Pharmaceuticals market cap hit its highest annual value?
- Vertex Pharmaceuticals market cap reached its highest annual value of $116.97B in 2025.
What was Vertex Pharmaceuticals market cap in 2025?
- Vertex Pharmaceuticals (VRTX) market cap in 2025 was $116.97B.
What was Vertex Pharmaceuticals market cap in 2026?
- Vertex Pharmaceuticals (VRTX) market cap in 2026 was $109.20B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
VRTX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.